Moreover, since these products bear a close resemblance to native proteins, they are ideally suited to the various in vitro biomarker and pharmacokinetic assays that our customers perform. Feedback tells us that by providing a more accurate representation of in vivo protein behaviour and activity, ACROBiosystems’ recombinant proteins allow researchers to generate more useful results.
We’ve recently noticed significant interest in ACROBiosystems’ immune checkpoint protein collection, which comprises unlabelled recombinant proteins in addition to proteins tagged with Fc, mouse Fc, His, and streptavidin. Other popular ACROBiosystems products include disease-associated biomarkers, CAR-T targets, and biosimilar development reagents such as target antigens and FcRN/FcgR reagents for biopharmaceutical antibody characterisation. This highlights the diversity of research that ACROBiosystems supports.